Synaptogenix, Inc. (SNPX)

Synaptogenix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	19.63	28.66	37.48	34.21	5.8	17.38
Short-Term Investments	2.44	1.44	-	-	-	-
Cash & Short-Term Investments	22.07	30.1	37.48	34.21	5.8	17.38
Cash Growth	-30.44%	-19.69%	9.54%	490.40%	-66.66%	-
Prepaid Expenses	0.21	0.43	1.11	1.29	0.93	0.49
Total Current Assets	22.28	30.53	38.59	35.5	6.73	17.88
Property, Plant & Equipment	0.01	0.02	0.02	0.02	0.02	0.02
Long-Term Investments	0.53	0.56	-	-	-	-
Total Assets	22.83	31.11	38.61	35.52	6.75	17.9
Accounts Payable	0.29	0.44	0.66	1.3	1.26	0.41
Accrued Expenses	0.05	0.44	0.54	0.7	0.35	0.07
Other Current Liabilities	-	3.4	0.12	-	-	-
Total Current Liabilities	0.34	4.28	1.31	1.99	1.61	0.48
Other Long-Term Liabilities	9.37	1.25	1.88	-	-	-
Total Liabilities	9.71	5.53	3.19	1.99	1.61	0.48
Common Stock	0	0	0	0	0	17.42
Additional Paid-In Capital	54.31	57.95	52.52	47.67	6.67	-
Retained Earnings	-41.51	-33.61	-19.83	-14.14	-1.53	-
Comprehensive Income & Other	0.01	0	-	-	-	-
Total Common Equity	12.8	24.35	32.69	33.53	5.14	17.42
Shareholders' Equity	13.12	25.58	35.41	33.53	5.14	17.42
Total Liabilities & Equity	22.83	31.11	38.61	35.52	6.75	17.9
Net Cash (Debt)	22.07	30.1	37.48	34.21	5.8	17.38
Net Cash Growth	-30.44%	-19.69%	9.54%	490.40%	-66.66%	-
Net Cash Per Share	19.95	64.58	134.06	170.55	115.20	345.55
Filing Date Shares Outstanding	1.36	1.09	0.29	0.27	0.14	0.12
Total Common Shares Outstanding	1.36	0.96	0.29	0.27	0.05	0.12
Working Capital	21.94	26.26	37.27	33.51	5.12	17.4
Book Value Per Share	9.44	25.27	112.47	124.55	102.15	141.15
Tangible Book Value	12.8	24.35	32.69	33.53	5.14	17.42
Tangible Book Value Per Share	9.44	25.27	112.47	124.55	102.15	141.15

Source: S&P Capital IQ. Standard template. Financial Sources.